Development and Characterization of Paclitaxel-Loaded Magnetic Nanoparticle-Embedded Transdermal Patches for Non-Invasive Breast Cancer Therapy
Nagaraja Sreeharsha1★, Shobana Nagaraj2★, Nimbagal Raghavendra Naveen2★, Prasidhhi Raikar2★, Prakash Goudanavar2★, Girish Meravanige3★, Predeepkumar Narayanappa Shiroorka3★, Krishna Swaroop3★★ Corresponding author
- 1Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Hofuf, Al-Ahsa, SAUDI ARABIA.
- 2Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G Nagara, Karnataka, INDIA.
- 3Department of Biomedical Sciences, College of Medicine, King Faisal University, Al-Ahsa, SAUDI ARABIA.
CORRESPONDENCE
Nagaraja Sreeharsha
Dr. Sreeharsha NagarajaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Hofuf, Al-Ahsa, SAUDI ARABIA.
Received: 20-09-2024; Revised: 06-12-2024; Accepted: 20-02-2025.
Volume 59, Issue 2 · pp. 617–627 · PUBLISHED Apr-Jun 2025 · DOI: 10.5530/ijper.20251989
ABSTRACT
Background Breast cancer remains a significant health concern, necessitating the development of advanced drug delivery systems for improved therapeutic outcomes. This study focuses on the design and evaluation of non-invasive transdermal patches incorporating magnetic nanoparticles (MNPs) for targeted Paclitaxel (PTX) delivery. Materials and Methods PTX-loaded MNPs were synthesized and characterized for particle size, zeta potential, drug loading capacity, and stability. The nanoparticles were embedded into transdermal patches formulated using Hydroxypropyl Methylcellulose (HPMC), ethyl cellulose (EC), polyethylene glycol 100 (PEG 100), and menthol to enhance permeation and provide controlled drug release. Physicochemical evaluations, in vitro drug diffusion studies using a Franz diffusion cell, and stability assessments were conducted. The release kinetics of the optimized formulation were analyzed to determine the drug release mechanism. Results The optimized PTX-MNP-loaded transdermal patch exhibited an entrapment efficiency of 96.83% and demonstrated prolonged drug release, following a non-Fickian (anomalous) transport mechanism, suggesting a combination of diffusion and polymer relaxation. Ex vivo permeation and stability studies confirmed the formulation’s efficiency and biocompatibility. Conclusion The developed PTX-MNP-loaded transdermal patch presents a promising non-invasive alternative for breast cancer therapy. Its sustained drug release profile, enhanced permeation, and biocompatibility make it a potential candidate for future clinical applications in targeted cancer treatment.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Sreeharsha, N., Nagaraj, S., Naveen, N. R., Raikar, P., Goudanavar, P., Meravanige, G., Shiroorka, P. N., & Swaroop, K. (2025). Development and Characterization of Paclitaxel-Loaded Magnetic Nanoparticle-Embedded Transdermal Patches for Non-Invasive Breast Cancer Therapy. Indian Journal of Pharmaceutical Education and Research, 59(2), 617–627. https://doi.org/10.5530/ijper.20251989
